Harvard Business Review

OCTOBER 13, 2011

The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk. Here, the protocols from other industries can provide some insight.

Banking 13

Banking Pharmaceuticals Microfinance Risk Management 13

Harvard Business Review

AUGUST 3, 2012

Their reliance on alliances and licenses has increased in both product development and marketing and they have become aggressive acquirers. So far have they moved, in fact, that they sometimes sound as if they have altogether abandoned their commitment to internal development. As yet, the facts don't seem to substantiate the fears.

Licensing 15

Licensing Depreciation Pharmaceuticals Budgeting 15

Harvard Business Review

FEBRUARY 23, 2011

The first part of the conference's message, that the infrastructure of the continent is greatly wanting, was a topic of many panels, including a pair of engaging ones on technology, but it was brought home most vividly in another context, by Thierry Tanoh , a vice president at the International Finance Corp.

Conference 15

Conference Pharmaceuticals Politics Entrepreneur 15

Harvard Business Review

JUNE 9, 2017

Equally troublesome, almost all policies focus exclusively on payments and finances but ignore the powerful influence of careerism and other non-financial motives that may compromise objectivity far more than financial incentives. Commonly, researchers develop a theory, then build a career gathering support for it.

Conflict of Interest 14

Conflict of Interest Pharmaceuticals Policies Industry 14

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 15

COO Sample Telecommunications Automotive 15

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. HR has the job of developing the human capabilities needed to capture the IoT opportunity.

Productivity 10

Productivity Products Company Engineering 10

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

MARCH 14, 2017

When one of us (Vivek) and his team launched Roivant Sciences in 2014 and began developing treatments for Alzheimer’s disease — they were determined to learn from the pharma industry’s innovation issues and build a more sustainable innovation engine. Roivant’s first response was to address misaligned incentives.

Innovation 13

Innovation Company Incentives Industry 13

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. Sample stocks in the ETF are the 100 companies which have the highest social contribution per share, and they are selected from a larger sample of about 300 companies that release their social responsibility reports and reassessed annually.

Long-term 15

Long-term Sample Report Pharmaceuticals 15

Harvard Business Review

APRIL 5, 2012

If you know market potential by account segment, you can scale and deploy sales resources appropriately against opportunities and can develop segment-appropriate value propositions and sales processes. Many sales forces do not have estimates of local market potential readily available, and developing them requires work and creativity.

Retail 11

Retail Incentives Tactics Pharmaceuticals 11

Harvard Business Review

OCTOBER 25, 2018

The superstars tend to be more involved in global flows of trade and finance, more digitally mature, and they dominate the lists of the most valued companies, the most valued brands, the most desirable places to work, and the most innovative companies. The churn rate of superstar cities is half that of superstar firms.

Industry 15

Industry Company GDP Bottom-up 15

Harvard Business Review

MAY 26, 2014

Top-tier thinkers from data science, business, finance, and the digital world are coming together to find new solutions. All of these developments spell the dawn of an exciting new era for entrepreneurs, techies, investors, clinicians, and, last but not least, patients. New players are fearlessly sensing the opportunity.

Health Care 10

Health Care Venture Funding Entrepreneur Pharmaceuticals 10

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Moving forward, consider the following questions for strategic development: Opportunity analysis. How could digital printing improve your innovation, product development, and speed to market?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

OCTOBER 20, 2016

Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988. pharmaceutical company, had to abandon its $106 billion attempt to buy British drug maker AstraZeneca in the face of opposition from UK politicians. This year, for example, the U.S.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

FEBRUARY 4, 2013

Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance. Breakthrough Access. Breakthrough involves a shift to new types of impact investment.

EPS 10

EPS Innovation CEO Pharmaceuticals 10

Harvard Business Review

MAY 15, 2013

Nor can we develop good approaches to analyzing, preserving and transforming cultures. If we can define what organizational culture is , it gives us a handle on how to diagnose problems and even to design and develop better cultures. finance vs. marketing) and units (e.g. The cultures of organizations are never monolithic.

Incentives 9

Incentives Definition Pharmaceuticals System 9

Harvard Business Review

JANUARY 26, 2016

and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields. One analyst told us that their company had stopped development on a project that was consuming lots of local resources after the analysis indicated it wouldn’t be effective.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. From a historical perspective, the idea that managers in organizations have a single, dominant duty — to achieve or maximize economic returns — is a striking development. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

JUNE 16, 2016

Pharmaceutical companies spend millions upon millions preparing meticulous plans for new drug launches – and yet their route-to-market strategies haven’t changed in decades, even though the reality of the market has. The failure stemmed from resistance in the U.S. What builds management perspectives?

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

SEPTEMBER 5, 2016

The UK’s Department for International Development uses “results-based” aid to improve the educational outcomes of young girls in Africa and Asia. Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

SEPTEMBER 21, 2015

Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. New managers like Terry can get stuck doing their subordinates’ jobs and keep their teams from developing the skills they need to succeed.

Management 8

Management Learning-by-Doing Pharmaceuticals Marketing 8

Harvard Business Review

AUGUST 23, 2018

By facilitating the transition from school to the labor force, summer jobs can help students apply what they learn in school, learn more work-related skills, and develop contacts with employers. My research shows that summer jobs for teens are important to their future prospects. Refocusing on Summer Jobs. Many large U.S.

Short-term 8

Short-term Participative Long-term Career 8

Harvard Business Review

MAY 5, 2016

Within weeks there was $50 billion in business deals involving foreign companies, including the Airbus agreement (worth $25 billion) to sell 118 planes, and Italy’s state rail company’s $5 billion pact to develop the local rail network. sanctions are delaying these projects being financed. However, remaining U.S.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

AUGUST 23, 2016

Republicans generally favor developing a pipeline of diverse candidates through director advocacy and mentorship, while Democrats are more likely to favor requiring that every director slate include diverse candidates, or that boards implement targets for diverse membership. chemicals, metals & mining, paper & forest products).

Politics 8

Politics Committee Telecommunications Diversity 8

Harvard Business Review

FEBRUARY 24, 2015

The outsiders provide new blood in support functions such as finance, legal, or administration. Decisive actions are required to tackle the factors that prompted the spin-off in the first place, which in many cases are underperformance and/or a lack of strategic fit leading to chronic underinvestment in the development of the business.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Marshall Goldsmith

FEBRUARY 8, 2018

14th Administrator, United States Agency for International Development. Rod MacKenzie – Executive Vice President, Chief Development Officer for Pfizer, member of Pfizer’s Executive Leadership Team. HR and talent development roles with General Motors Australia. Darek Lenart – Senior VP HR, Finance MasterCard.

Executive Coaching 70

Executive Coaching CEO Banking Magazine 70

Chartered Management Institute

FEBRUARY 26, 2024

In all sectors, tensions exist between competing pressures such as resources, finance, time and workload. Please login to the left to confirm your registration and access the article. The competitive landscape tends to reward those who are prepared to push them to the limit.

Uncertainty 52

Uncertainty Risk Management Training Learning-by-Doing 52

Harvard Business Review

OCTOBER 26, 2011

Solyndra's example has been particularly stark: it raised over $1 billion in equity finance in addition to receiving a $535 million loan guarantee from the Department of Energy, all prior to a cancelled IPO and the recent FBI investigation upon its bankruptcy.

Energy 14

Energy Finance IPO Biotechnology 14

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets. Facilitate discussion between competitors.

Apparel 16

Apparel Pharmaceuticals Finance Licensing 16

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

The Horizons Tracker

NOVEMBER 29, 2023

However, the research also highlights the significance of diverse educational, industrial, and organizational backgrounds among managers and board members in fostering innovation in research and development (R&D), thereby generating both economic and social value.

Diversity 111

Diversity Innovation Biotechnology Short-term 111

Harvard Business Review

JULY 4, 2017

Apple is so great at connectivity, aesthetics, and entertainment that any vehicle they develop will incorporate these as table stakes. One way to appeal to this demographic (and to the parents who often finance young drivers’ transportation) is to focus on safety. How about a man cave on wheels? Or a kitchen?

Transportation 13

Transportation Sports Pharmaceuticals Health Care 13

Harvard Business Review

NOVEMBER 20, 2015

One result is that they keep their cards close to their chests about what they are looking for (at first), while expecting you to reveal everything – your finances, pricing, ownership, human resources, production processes, quality assurance, customer service procedures, KPIs, and existing customers.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

NOVEMBER 10, 2017

Spending on corporate learning, particularly leadership development, continues to increase at a staggering pace. According to one piece of research , spending on frontline leadership development alone increased by over 310% in a three-year period. Pat Canova/Getty Images. Insight center. The Gap Between Strategy and Execution.

Skills 15

Skills Learning-by-Doing Agility Content 15

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Resistant forms continue to thrive, and increased travel makes the global threat very real.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8